Stories
of life-changing
value creation and delivery
Filter
Kyowa Kirin International: It's Time to Shine A Light on XLH
Patients | June 27, 2022
Kyowa Kirin CEO Miyamoto’s Message on Pride Month
People & Culture | June 9, 2022
Pharmacovigilance Activities (Part II): Adopting a Momotaro Mindset to Overcome Challenges - Global PV Function Member Dialogue -
Patients | March 10, 2022
Pharmacovigilance Activities (Part I): Bringing Smiles to Patients by Supporting Medicinal Product Safety Monitoring Activities on a Global Scale
Patients | February 22, 2022
Kyowa Kirin International Celebrates the UN’s International Day of Persons with Disabilities in EMEA
People & Culture | January 20, 2022
Kyowa Kirin International: Around the world challenge
People & Culture | December 17, 2021
Kyowa Kirin North America: Honoring The Caregiver, Everyday Heroes, During National Family Caregivers Month
Patients | November 19, 2021
Kyowa Kirin's Effort to Realize a Sustainable Society
Sustainability | October 11, 2021
Our Financial Strategy for Creating Life-changing Value
Growth | September 9, 2021
Changes in society caused by COVID-19 and the impact on Kyowa Kirin
Growth | August 19, 2021
Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break
Sustainability | July 27, 2021
AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS
News Release | June 1, 2021
MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting
News Release | May 20, 2021
White Paper on the unrecognized burden of XLH in adults in Europe
Patients | July 13, 2020
